Smoking Cessation Support for Patients With Rheumatologic Diseases Via WhatsApp
Key facts
- Who runs it
- Recep Tayyip Erdogan University Training and Research Hospital
- Where
- Türkiye1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Terminated
- People taking part
- 220 people enrolled
- Started
- 10 Nov 2023
- Ended
- 30 Jun 2025
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Mobile messages via What's App
- Record updated
- 25 July 2025
- Why it stopped
- Enough participants included to the study.
Who can take part
- Age
- 18 years to 80 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
Show the full registry criteria (7)Hide the full registry criteria
Who can take part
- Patients applying to the rheumatology outpatient clinic
- Those aged 18 and over
- Those who are active smokers
- Those diagnosed with inflammatory rheumatic disease
- Those who gave informed written consent to participate in the study
Who cannot take part
- Those with active psychiatric disease diagnoses such as psychosis, major depression, schizophrenia among their current diagnoses
- Those with cognitive dysfunction
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Smoking cessation support for patients with rheumatologist diseases is an underestimated issue. In the previous prospective cohort study the investigators determined that with the brief cessation interventions 63.5% of smokers with rheumatologic diseases were willing to quit and the rest 36.4% were not willing. Among the willing group the highest quit rate was detected in the group that admitted to smoking cessation clinic. Therefore to increase the willingness to quit as well as to increase the Access to evidence based tobacco cessation support using new comminication technologies can be relevant. Investigators' aim in this study is to examine the effect of including WhatsApp in the routine smoking cessation practices on the quitting success of active smokers with rheumatic diseases who apply to the Rheumatology outpatient clinic.
The 2 groups in the trial
- Usual careExisting treatment, for comparison
Usual care arm, smoker patients with rheumatologist diseases will be implemented brief smoking cessation interventions and referred to quit lines or smoking cessation services and also directly contacted to get an appointment from the cessation clinic.
Treatment: Mobile messages via What's App
- InterventionTreatment being tested
The intervention arm, smoker patients with rheumatologist diseases will be implemented brief tobacco cessation interventions and directly contacted to get an appointment from cessation clinic and will be send periodically motivational and informative text messages regarding tobacco cessation via WhatsApp.
Treatment: Mobile messages via What's App
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- The Effect of Supporting Routine Smoking Cessation Interventions With Whatsapp-mediated Motivational Information on Smoking Cessation Success in Active Smokers With Inflammatory Rheumatic Diseases: A Randomized Controlled Study
- Record updated
- 25 July 2025